Arovella Therapeutics Limited ( (AU:ALA) ) has issued an announcement.
Arovella Therapeutics Limited, a company trading on the Australian Securities Exchange, has requested a voluntary suspension of its securities. This suspension, effective immediately, is to allow the company to manage its disclosure obligations related to an impending capital raising announcement. The suspension will remain until either the market announcement is made or normal trading resumes on February 17, 2025. This move is likely to impact stakeholders by temporarily halting trading activities for Arovella’s securities, indicating significant forthcoming business developments.
More about Arovella Therapeutics Limited
YTD Price Performance: 14.71%
Average Trading Volume: 1,282,294
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$207.5M
For an in-depth examination of ALA stock, go to TipRanks’ Stock Analysis page.